The Valley Desk

NCT06936566 · Interventional trial

MAGIC Ruxolitinib for aGVHD

Overall registry status Recruiting

Phase 2

Conditions Acute Graft-versus-host Disease, Adverse Effects, Allogeneic Bone Marrow Transplantation

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov